Compile Data Set for Download or QSAR
Report error Found 124 of affinity data for UniProtKB/TrEMBL: Q01650
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781570((S)-2-Amino-3-(5-(N-(3-bromophenyl)sulfamoyl)-2-me...)
Affinity DataIC50: 9nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781573((S)-2-Amino-3-(5-(N-(4-chlorophenyl)sulfamoyl)-2-i...)
Affinity DataIC50: 10nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781572((S)-2-Amino-3-(5-(N-(4-methoxyphenyl)sulfamoyl)-2-...)
Affinity DataIC50: 10nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781575((S)-2-Amino-3-(5-(N-(4-chlorophenyl)sulfamoyl)-2-m...)
Affinity DataIC50: 12nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781574((S)-2-Amino-3-(5-(N-(4-bromophenyl)sulfamoyl)-2-me...)
Affinity DataIC50: 12nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781576((S)-2-Amino-3-(5-(N-benzylsulfamoyl)-2-methylpheny...)
Affinity DataIC50: 20nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781577((S)-2-Amino-3-(2-methyl-5-(N-(naphthalen-1-yl)sulf...)
Affinity DataIC50: 24nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781578((S)-3-(5-(N-([1,1'-Biphenyl]-4-yl)sulfamoyl)-2-met...)
Affinity DataIC50: 25nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781579((S)-2-Amino-3-(2-methyl-5-(N-phenylsulfamoyl)pheny...)
Affinity DataIC50: 30nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781581((S)-3-(5-([1,1'-Biphenyl]-3-sulfonamido)-2-methylp...)
Affinity DataIC50: 40nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781580((S)-2-Amino-3-(5-((3-bromophenyl)sulfonamido)-2-me...)
Affinity DataIC50: 40nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781582((S)-2-Amino-3-(5-((5-(dimethylamino)naphthalene)-1...)
Affinity DataIC50: 50nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781583((S)-2-Amino-3-(5-(N-butylsulfamoyl)-2-methylphenyl...)
Affinity DataIC50: 56nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50532381(CHEMBL4538666)
Affinity DataIC50: 60nMAssay Description:Inhibition of [14C]-L-leucine uptake at LAT1 in human HT-29 cells after 1 hr by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50532381(CHEMBL4538666)
Affinity DataIC50: 60nMAssay Description:Inhibition of [14C]-L-leucine uptake at LAT1 in human HT-29 cells after 1 hr by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781584((S)-2-Amino-3-(5-(N-cyclohexylsulfamoyl)-2-methylp...)
Affinity DataIC50: 60nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781586((S)-2-Amino-3-(5-(N-(5-(dimethylamino)naphthalen-1...)
Affinity DataIC50: 80nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781585((S)-2-Amino-3-(3-(N-(4-chlorophenyl)sulfamoyl)phen...)
Affinity DataIC50: 80nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781588((S)-2-Amino-3-(5-((4-(tert-butyl)phenyl)sulfonamid...)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM781587((S)-2-Amino-3-(2-methyl-5-(phenylsulfonamido)pheny...)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to interact with LAT1 was measured using a radiolabeled competition uptake assay with [3H]-Gabapentin ([3H]-GP) (Perkin Elme...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/5/2026
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50532381(CHEMBL4538666)
Affinity DataIC50: 790nMAssay Description:Inhibition of [14C]-L-leucine uptake at LAT1 in human YD-38 cells after 1 hr by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50532381(CHEMBL4538666)
Affinity DataIC50: 790nMAssay Description:Inhibition of [14C]-L-leucine uptake at LAT1 in human YD-38 cells after 1 hr by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50528545(CHEMBL4526588)
Affinity DataIC50: 980nMAssay Description:Inhibition of recombinant human LAT1More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50652793(CHEMBL5653589)
Affinity DataKd:  1.19E+3nMAssay Description:Binding affinity to human SLC7A5 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50652792(CHEMBL3752910)
Affinity DataKd:  2.22E+3nMAssay Description:Binding affinity to human SLC7A5 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50540285(CHEMBL4642431)
Affinity DataIC50: 3.48E+3nMAssay Description:Induction of LAT1-mediated polyamine efflux in human L3.6PL cells assessed as reduction in cell viability after 48 hrs by MTS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50174344(CHEMBL58129)
Affinity DataIC50: 6.60E+3nMAssay Description:Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50174344(CHEMBL58129)
Affinity DataIC50: 6.60E+3nMAssay Description:Inhibition of human LAT1 expressed in HEK cells assessed as reduction in uptake of [3H]-gabapentin after 3 mins by scintillation counting based cis-i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2017
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50174345(CHEMBL3809112)
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of human LAT1 expressed in HEK cells assessed as reduction in uptake of [3H]-gabapentin after 3 mins by scintillation counting based cis-i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2017
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50174345(CHEMBL3809112)
Affinity DataIC50: 7.30E+3nMAssay Description:Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50174343(CHEMBL3809645)
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibition of human LAT1 expressed in HEK cells assessed as reduction in uptake of [3H]-gabapentin after 3 mins by scintillation counting based cis-i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2017
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340672(US9771316, Example 70)
Affinity DataIC50: 1.04E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50463188(CHEMBL4248463)
Affinity DataIC50: 1.70E+4nMAssay Description:Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50532380(CHEMBL4522605)
Affinity DataIC50: 1.82E+4nMAssay Description:Competitive inhibition of [14C]-L-leucine uptake at LAT1 in human MCF7 cells preincubated for 5 mins followed by addition of substrate measured durin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50532380(CHEMBL4522605)
Affinity DataIC50: 1.82E+4nMAssay Description:Competitive inhibition of [14C]-L-leucine uptake at LAT1 in human MCF7 cells preincubated for 5 mins followed by addition of substrate measured durin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50606666(CHEMBL5219332)
Affinity DataIC50: 1.82E+4nMAssay Description:Inhibition of LAT1 in human MCF7 cells assessed as inhibition of leucine uptakeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM181118(US9138393, Histidine | US9144538, Histidine)
Affinity DataIC50: 2.00E+4nMAssay Description:Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50463321(CHEMBL4239455)
Affinity DataIC50: 2.77E+4nMAssay Description:Inhibition of LAT1-mediated [14C]-L-leucine uptake in human MCF7 cells after 5 mins by liquid scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50463211(CHEMBL4244215)
Affinity DataIC50: 2.90E+4nMAssay Description:Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50463322(CHEMBL4242544)
Affinity DataIC50: 3.24E+4nMAssay Description:Inhibition of LAT1-mediated [14C]-L-leucine uptake in human MCF7 cells after 5 mins by liquid scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM50463202(CHEMBL4241703)
Affinity DataIC50: 3.60E+4nMAssay Description:Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340669(US9771316, Example 68)
Affinity DataIC50: 3.64E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340672(US9771316, Example 70)
Affinity DataIC50: 3.66E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340542(US9771316, Example 44)
Affinity DataIC50: 3.94E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM36161(D-phenylalanine)
Affinity DataIC50: 4.60E+4nMAssay Description:Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340549(US9771316, Example 48)
Affinity DataIC50: 5.66E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340539(US9771316, Example 26)
Affinity DataIC50: 5.70E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340532(US9771316, Example 1)
Affinity DataIC50: 5.75E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340661(US9771316, Example 66)
Affinity DataIC50: 6.28E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

TargetLarge neutral amino acids transporter small subunit 1(Human)
Maxymune Therapeutics

US Patent
LigandPNGBDBM340536(US9771316, Example 12)
Affinity DataIC50: 6.30E+4nMAssay Description:Expression vector each expressing a gene was inserted using Lipofectamine 2000 (Invitrogen) to cultured cell line HEK293 cell derived from human fetu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/2/2019
Entry Details
US Patent

Displayed 1 to 50 (of 124 total ) | Next | Last >>
Jump to: